肺癌查的现在和未来:最新证据
Juan Gutiérrez Alliende1, Ella A Kazerooni2, Philip A J Crosbie3
1Medical Affairs for Digital Radiology, Bayer AG, Berlin, Germany.
Future oncology (London, England)
|May 9, 2025
概括
早期发现肺癌显著提高了生存率. 本次网络研讨会探讨了肺癌查 (LCS) 的当前证据,挑战和人工智能 (AI),突出了AI.
科学领域:
- 在瘤学瘤学.
- 医疗成像医学成像
- 公共卫生 公共卫生
背景情况:
- 肺癌仍然是全球癌症死亡的主要原因之一.
- 通过肺癌查 (LCS) 早期检测对于改善患者存活率至关重要.
- 现有的LCS计划在实施和管理方面面临挑战.
研究的目的:
- 总结专家对肺癌查最新证据的观点.
- 讨论有效实施肺癌查的障碍.
- 探索人工智能 (AI) 在推动LCS方面的作用和潜力.
主要方法:
- 该研究是国际网络研讨会的演讲和小组讨论的总结.
- 从美国,英国和中国收集了专家意见.
- 关键话题包括基于证据的建议,管理策略和LCS中的AI应用.
主要成果:
- 人工智能 (AI) 提出了潜在的解决方案,以克服肺癌查方面的挑战.
- 几个国家正在将AI整合到他们的查计划中.
- 专家的共识强调了基于证据的实践和解决实施障碍的重要性.
结论:
- 肺癌查 (LCS) 的有效性通过早期检测和强有力的管理得到增强.
- 人工智能 (AI) 准备在优化未来肺癌查计划方面发挥重要作用.
- 国际合作和基于证据的方法对于推动全球LCS至关重要.
更多相关视频
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
15.6K
11:31Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer
Published on: May 20, 2016
10.7K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
